Literature DB >> 8641815

Mass transfer limitations to the performance of membrane bioartificial liver support devices.

G Catapano1.   

Abstract

A number of membrane bioartificial devices have been proposed for liver support. However, their design does not yet ensure the successful treatment of acute liver insufficiency. In this paper, the Author reviews the limitations of the mass transport phenomena to the performance of a membrane bioartificial liver support device. First of all the requirements that an optimal membrane bioartificial liver support device has to meet for the therapy to be effective are presented. On these grounds, the issues that are still to be addressed to optimize the performance of such devices are discussed: particular attention is devoted to the mass transport phenomena in each region of the membrane bioartificial device. Finally, the main transport features of the membrane bioartificial liver support devices proposed so far are illustrated and examined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641815

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  5 in total

1.  Hemoglobin regulates the metabolic, synthetic, detoxification, and biotransformation functions of hepatoma cells cultured in a hollow fiber bioreactor.

Authors:  Guo Chen; Andre F Palmer
Journal:  Tissue Eng Part A       Date:  2010-10       Impact factor: 3.845

2.  Three-dimensional numerical modeling and computational fluid dynamics simulations to analyze and improve oxygen availability in the AMC bioartificial liver.

Authors:  Guy Mareels; Paul P C Poyck; Sunny Eloot; Robert A F M Chamuleau; Pascal R Verdonck
Journal:  Ann Biomed Eng       Date:  2006-10-10       Impact factor: 3.934

3.  Evaluation of diffusion in gel entrapment cell culture within hollow fibers.

Authors:  Dan-Qing Wu; Guo-Liang Zhang; Chong Shen; Qian Zhao; Hui Li; Qin Meng
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

4.  Engineering a perfusable 3D human liver platform from iPS cells.

Authors:  Arnout Schepers; Cheri Li; Arnav Chhabra; Benjamin Tschudy Seney; Sangeeta Bhatia
Journal:  Lab Chip       Date:  2016-07-05       Impact factor: 6.799

5.  Impact of alginate composition: from bead mechanical properties to encapsulated HepG2/C3A cell activities for in vivo implantation.

Authors:  Stephanie H Capone; Murielle Dufresne; Mathias Rechel; Marie-José Fleury; Anne-Virginie Salsac; Patrick Paullier; Martine Daujat-Chavanieu; Cecile Legallais
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.